tradingkey.logo

BRIEF-GSK Posts Q4 Turnover 8.12 Bln Stg VS IBES Estimate 7.75 Bln Stg

ReutersFeb 5, 2025 7:07 AM

- GSK plc GSK.L:

  • GSK PLC - FINAL RESULTS

  • GSK: £2 BILLION SHARE BUYBACK PROGRAMME TO BE IMPLEMENTED OVER NEXT 18 MONTHS

  • GSK Q4 TURNOVER 8,117 MILLION POUNDS VERSUS IBES ESTIMATE 7,750 MILLION POUNDS

  • GSK: 2031 SALES OUTLOOK INCREASED TO MORE THAN £40 BILLION

  • GSK Q4 ADJUSTED EPS 23.2 P VERSUS IBES ESTIMATE 19.01 P

  • GSK: SALES OF MORE THAN £40 BILLION NOW EXPECTED BY 2031

  • GSK OUTLOOK 2025 VACCINES EXPECTED DECREASE OF A LOW SINGLE-DIGIT PER CENT IN TURNOVER

  • GSK: INCREASING AND PRIORITISING RESEARCH AND DEVELOPMENT INVESTMENT TO PROMISING NEW LONG-ACTING AND SPECIALTY MEDICINES

  • GSK - DIVIDEND 64P EXPECTED FOR 2025

Source text: ID:nRSE9111Va

Further company coverage: GSK.L

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI